We are Healthcare Entrepreneurs
with a collective skill set that brings value to the healthcare startups we support.

Clinicians,Investigators,Innovators,Healthcare Entrepreneurs,Executives

Apply for investment

About Us

We foster partnerships with entrepreneurs and innovators who - like us- are relentless about unlocking new, bold opportunities for enhancing health and wellness. Together, we endeavor to simplify healthcare, making it more accessible, affordable, and predictable for individuals worldwide.

Our Mission

Our Mission

Our mission is twofold: to enhance the availability of clinical tools in the market while delivering outstanding returns for our investors.

Investment Focus

Extremely capital-efficient with high valuation growth potential

Backed by academic or university support

Preference for clinical development stage over technology development stage

Have potential for global impact

Seek involvement of our members on their board or scientific advisory panel

Investment Focus

Testimonials

“Angel Physicians Fund have given us valuable clinical advice and helped us in new product development, along with obtaining FDA breakthrough device status. We are indeed very thankful to them, as they have helped us beyond capital in our endeavor to enhance cancer care.”

Vedang Kothari

President, MuReva Photodynamic Therapy

“Angel Physicians Fund is more than an investor in Kurome Therapeutics. Their members serve as trusted technical advisors and also bring the much needed clinical perspective to our development program. We highly value their contributions.”

Jan S. Rosenbaum, Ph.D.

President & CEO, Kurome Therapeutics, Inc.

"We at Immunogenesis have found a terrific partner in the Angel Physicians Fund. They have been extremely resourceful in helping us complete our Series A funding, providing us clinical trial sites and Dr Bhandari's clinical insights on our Board are very much appreciated. They are a terrific partner and a great resource to us."

Michael Curran

Founder & Scientific Advisory Board Head, Board Member of Immunogenesis

“The Angel Physicians Fund and its clinical advisory team have been instrumental in our product development. They are a great partner.”

Saar Mahna

Founder & CEO, Banjo Health

“Angel Physicians Fund has provided a significant value-add to Foldax in accelerating our product and clinical development. Their physician-based expertise and experience have been instrumental in the Company's progress.”

Ken Charhut

Executive Chairman of the Board, Foldax Inc.

“Angel Physician Fund has provided significant value to Enable in our mission to become the standard of care alternative to intravenous drug administration and we greatly appreciate their support.”

Michael Hooven

President & CEO, Enable Injections, Inc.

Vedang Kothari

President, MuReva Photodynamic Therapy

Jan S. Rosenbaum, Ph.D.

President & CEO, Kurome Therapeutics, Inc.

Michael Curran

Founder & Scientific Advisory Board Head, Board Member of Immunogenesis

“The Angel Physicians Fund and its clinical advisory team have been instrumental in our product development. They are a great partner.”

Saar Mahna

Founder & CEO, Banjo Health

Ken Charhut

Executive Chairman of the Board, Foldax Inc.

Michael Hooven

President & CEO, Enable Injections, Inc.

Vedang Kothari

President, MuReva Photodynamic Therapy

Portfolio

Taking an active role, we leverage our collective expertise to accelerate the growth of our portfolio companies.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Alphyn Biologics

A life science company creating a new class of drugs, Multi-Target Therapeutics™ - designed for more powerful and effective therapies utilizing patented multiple natural bioactive derivatives to target the most difficult, severe and prevalent skin diseases facing humankind.

Bio Pharma

Aria CV

ARIA CV is developing an implantable medical device aimed at improving the lives of patients living with Pulmonary Arterial Hypertension (PAH). The device has received FDA Breakthrough Designation.

Med Tech

Ariz Bio

ARIZ (Pronounced “ARISE”) uses nano-technology to deliver therapeutics to individually target and destroy cancer cells, while sparing normal cells. ARIZ’s therapeutic targets are a family of gene targets known as the PRDMs (Positive Regulatory Domain-containing Methyltransferase).

Bio Pharma

Armatus Bio

We are building a synergistic, multi-asset pipeline using RNAi to target gene silencing and replacement. This allows us to target a range of diseases for communities with few or no therapeutics today. Our lead candidates are in preclinical stages for rare neuromuscular diseases, providing hope for conditions with limited or no current treatments.

Bio Pharma

Avive AED

The Avive Connect AED™ is packing first of it’s kind capabilities and the most advanced features in the industry into a smaller, intuitive, more affordable, and cloud connected device. This new device sets a new standard for what should be expected of an AED.

Med Tech

Banjo Health

Banjo Health uses AI and machine learning to streamline the Prior Authorization process in healthcare. By reducing inefficiencies, the platform helps health plans, PBMs, and providers improve patient care. Banjo Health offers customized, AI-driven solutions for more efficient and effective authorization workflows.

Digital Health / AI

BlinkPad

Provider of a talent search platform designed to streamline the hiring process. The platform meets all candidate sourcing and networking needs, offering multiple ways to showcase information for quick business insights. It enables the healthcare and hospitality industries to connect with talent seamlessly in real-time.

Digital Health / AI

Brixton Bio

Developer of novel therapies for chronic and acute pain. The company's treatment involves a simple injection that induces reversible nerve inhibition, providing pain relief that lasts much longer than current methods. Patients can experience pain relief for 30 to 60 days from a single injection.

Med Tech

Clint

HealthPals' CLINT is an AI engine developed by Stanford experts to analyze patient data and identify actionable care gaps for therapeutic and diagnostic interventions. CLINT optimizes patient care, accelerates clinical trial recruitment, and predicts health outcomes. HealthPals works with life sciences, health systems, and payers, offering advanced risk models for clinical trials and patient outcomes.

Digital Health / AI

ConKay

Conkay Medical has developed a device to treat valvular regurgitation in patients with progressive heart failure. Utilizing annular repair technology, the device addresses the main cause of functional regurgitation while preserving healthy valve leaflets. This innovation helps healthcare professionals improve cardiovascular care.

Med Tech

Conformal Medical

Conformal Medical focuses on reducing strokes in atrial fibrillation patients through Left Atrial Appendage (LAA) closure, offering an alternative to long-term blood thinners without bleeding risks or daily medication. The Conformal LAA Seal (CLAAS) is designed to fit each patient's unique anatomy, providing intuitive use and lowering care costs.

Med Tech

Elucid Bioimaging

Elucid is advancing precision medicine for cardiovascular imaging with its FDA-cleared VascuCap software. This CE-marked diagnostic tool is the only non-invasive clinical software that quantifies vascular lipid-rich necrotic core, validated against histopathology, providing crucial insights for cardiovascular disease treatment.

Digital Health / AI

Epitel

Epitel's first product features four wireless, wearable EEG sensors and software that connects neurologists to real-time recordings for remote patient monitoring. These sensors offer an easy-to-use solution for both in-hospital monitoring and home seizure detection, enabling continuous care and tracking.

Med Tech

Eyecool

Stealth Mode

Med Tech

Foldax

Foldax, Inc. has developed Tria™ heart valves using a revolutionary LifePolymer™ material, designed for lifetime durability. These valves aim to provide cost-effective treatment for patients with aortic, mitral, and tricuspid valve disease, offering a long-lasting solution through a single heart valve procedure.

Med Tech

Immunogenesis

Immunogenesis develops immuno-oncology therapeutics to treat cold tumors. Specializing in immunotherapies that trigger immune responses in cancers like prostate, colorectal, and pancreatic, the company offers therapies that target immune resistance, improving cancer treatment outcomes.

Bio Pharma

Instylla

Instylla’s focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis.

Med Tech

Kurome Therapeutics

Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.

Bio Pharma

Moray Medical

Moray Medical is working to improve the quality of life for the millions suffering with leaky heart valves. Using the proprietary microfluidic robotics, more cardiologists will safely and cost-effectively be able to treat the large number of patients who need mitral valve clip therapies.

Med Tech

MuReva Phototherapy

MuReva is a medical device innovator using photobiomodulation to treat and potentially prevent mucosal injury, affecting over 3 million cancer patients annually. Their first clinical trials focus on head and neck cancer patients undergoing radiation and chemotherapy.

Med Tech

PanTher Therapeutics

PanTher has developed a novel delivery method that targets chemotherapy directly to the tumor, reducing toxicity and debilitating side effects from traditional IV or oral administration. This approach aims to increase drug concentration at the tumor site, improving therapeutic efficacy.

Bio Pharma

Promaxo

Promaxo offers the first FDA-cleared, portable, single-sided MRI system for use in physician offices and outpatient centers. Combining AI, robotics, and minimally invasive imaging, the Promaxo MRI goes beyond traditional screening, incorporating robotics for biopsy guidance and treatment.

Med Tech

S4 Medical

S4 Medical is focused on creating safer, more effective catheter ablation treatments. Their device is designed to deviate the esophagus, reducing the risk of thermal injury during atrial fibrillation ablation, helping protect the esophagus while allowing precise control for the electrophysiologist.

Med Tech

SPECT

Spect’s mission is to prevent blindness with the early detection of eye disease and to build a platform for healthcare data analytics.

Med Tech

Sense Neuro Diagnositics

Sense Neuro is developing non-invasive technology for rapid detection and continuous monitoring of stroke subtypes and traumatic brain injury. With "time is brain" in mind, Sense aims to deliver timely, accurate treatment. Sense was named among the global top 5 emerging neurological device startups.

Med Tech

Simergent

Simergent is the developer of an automated peritoneal dialysis device designed to make home dialysis affordable in emerging markets. The device is cost-effective, easy to use, and includes a disposable tubing set, providing patients with an accessible and simple home dialysis solution.

Med Tech

Sword Bio

Sword Bio is made up of experts in the bioanalytical CRO market who share the mission of our customers, quickly bringing important drugs to the people in need.

Bio Pharma

TPA Stream

TPA Stream is the developer of a SaaS platform with AI tools to simplify healthcare claims administration for small and medium-sized businesses. Their software assists Third Party Administrators in managing consumer-directed healthcare and COBRA benefits with real-time claims harvesting, invoicing, and integrations.

Digital Health / AI

TomBot

Tombot has created robotic pets to help millions of people facing health adversities and elders with cognitive impairment who cannot safely or practically care for a live animal companion. The medical advantages are being investigated with a plan to develop the first FDA approved medical compliance and patient monitoring device via a robotic pet.

Med Tech

Valitor Bio

Valitor, Inc. has developed novel methods to modify therapeutic proteins, providing greater control over pharmacokinetics, target specificity, and bioactivity. Their platform improves protein drug properties, with a lead product targeting ophthalmology and additional pipelines in oncology and orthopedics.

Bio Pharma

Vitruviae

VITRUVIAE is a preclinical biotechnology company developing immunotherapies targeting Man 9 (a sugar) and PS (a lipid) to treat cancer. Their lead therapy, VIT-GLT3, is a trispecific immunotherapy that targets tumor-specific, non-mutating Man9 and PS, aiming to overcome the limitations of current antitumor treatments.

Bio Pharma

We collaborate closely with founders and management teams, offering strategic guidance, mentorship, and operational support. By fostering strong partnerships and providing valuable resources, we empower our portfolio companies to overcome challenges, seize opportunities, and achieve their full potential. Together, we are dedicated to accelerating growth, maximizing value creation, and making a meaningful impact in the healthcare industry.

Expertise

Vetted for deep expertise in health sciences

Seasoned in achieving successful exits from healthcare ventures

Possess deep-rooted academic, corporate, and financial networks

Utilize strategic relationships to open doors at renowned institutions

Facilitate co-investments and sidecar investments to support capital raise

Provide hands on guidance

Support

Serving as board members or scientific advisory panel members

Advancing clinical studies through clinical engagement, developing and fast-tracking clinical protocols, and facilitating

Executing thorough cost of care studies to validate payor/reimbursement strategies

Exploring markets and conducting meticulous feasibility studie